Clinical Trials Browser

Phase 1/2 × Carcinoma, Non-Small-Cell Lung × Clinical Trials, Phase I as Topic × Clear all

NCT02382406 2023-05-23

Carboplatin/Nab-Paclitaxel and Pembrolizumab in NSCLC

Phase 1/2 Terminated

46 enrolled 24 charts

Carcinoma, Non-Small-Cell Lung